Ondansetron for vomiting in acute stomach infection (with placebo)
Treatments studied
Part of Digestive system clinical trials.
This Phase 3 trial tests whether ondansetron (a medicine used to reduce nausea and vomiting) works better than a placebo, along with usual care, for adults with acute gastroenteritis. It also checks how safe ondansetron is in this setting, especially for the heart rhythm and other side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult aged 18 to 65.
- You have acute gastroenteritis and are being seen in the emergency room.
- A doctor thinks you need medicine to prevent or treat vomiting (anti-nausea/anti-vomiting medicine).
- You can sign consent and follow all study instructions during the trial.
- You have not taken an anti-vomiting medicine in the last 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a nausea medicine called ondansetron helps people feel better and lets doctors work more efficiently during a camera test (endoscopy) for upper GI bleeding. If you need an emergency endoscopy for bleeding, ondansetron may reduce discomfort.
This trial tests whether ondansetron can improve stomach “sensorimotor” problems—how the gut senses food and moves it—especially in people with diabetes and troubling indigestion. It may help reduce symptoms like early fullness, nausea, and discomfort after eating.
This study tests two different medication combinations to prevent nausea and vomiting after laparoscopic gallbladder removal surgery. You'll receive either ondansetron plus metoclopramide, or dexamethasone plus metoclopramide, and researchers will track how quickly you need rescue medication if nausea occurs.
This trial compares two anti-nausea medicines (fosaprepitant and metoclopramide) given in the emergency room to see which works better for adults with nausea or vomiting. If you qualify, you would receive one of the study medications and have follow-up calls to check how you're feeling.
This Phase 2 study tests whether ondansetron can help prevent future fainting (vasovagal syncope) in adults who have had recent episodes. If it works, it may reduce how often you faint and improve safety in everyday situations.
This trial tests whether ondansetron, a medicine that helps control nausea and vomiting, can reduce the risk of pancreatitis (inflammation of the pancreas) after an ERCP procedure. If you are scheduled for an ERCP and do not have certain health issues, you may be able to join.
Hear when a new Gastroenteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.